Flow Cytometry Services

Unique flow cytometry services implemented with customizable solutions are designed to meet your clinical trial needs across the globe

With an exponential growth in the area of personalized medicine and in particular immuno-oncology, Q2 Solutions is a leader of flow cytometry companies with the largest global footprint for flow cytometry services, innovative technology that provides high quality data with minimal variability, and continuous improvement efficiency initiatives to meet customers’ individual study needs.

Flow cytometry solutions

Q2 Solutions’ customers have access to global central laboratories, including three satellite translational science assay development laboratories, that are equipped with industry leading development expertise and value-added offerings that bring their drugs to market faster.

Our experienced assay development scientists, scientific advisors, immunologists, geneticists, pathologists, and bioinformaticists in our global central laboratories each play a key role in providing continued engagement with sponsors and providing custom solutions that fit our customers’ needs, such as defining flow cytometry assays and cytokine assays, and identifying flow cytometry assay development challenges.

Our integrated flow cytometry team includes translational science, clinical laboratory, and global cytometry teams
flow cytometry teams of translational science, clinical laboratory, and global cytometry

Flow Cytometry and Immunoassays for Immuno-Oncology Biomarkers:
  • Immuno-Phenotyping
  • Receptor Occupancy
  • TILs
  • Intracellular Cytokine Survey
  • Minimal Residual Disease (MRD)
  • Circulating Soluble Proteins

We have the largest flow cytometry footprint in the world with our labs around the globe equipped with clinical trial sample production BD FACSCanto 8-10 color instruments, which provide a more complete flow cytometry data set more efficiently for our customers.

We also implement an integrated scientific approach that drives successful immuno-oncology clinical studies. Download our flow cytometry brochure to learn more.

Intensive flow cytometry training

We take the necessary steps to ensure our customers’ clinical trial success along the drug development continuum. An intensive flow cytometry training program supports assays new to our facilities that include bench training on sample processing; data acquisition and troubleshooting; data interpretation and analysis; and ongoing internal proficiency testing schemes. 

From custom flow cytometry panel design to review of the validation report, data, technology transfer and more, we encourage sponsor engagement throughout the process.

Learn more about our Quality Management System that gives you confidence in the data we deliver.

Flow Cytometry lab partner for your success

We employ a unique quantitative standardization system in conjunction with automated offsets of daily variation in instruments to provide a proficient and cost-effective flow cytometry production environment for your study.

Using these resources, plus many more, we are shaping the healthcare market landscape with unique, customizable clinical trial flow cytometry services. We recently announced our deployment of next generation flow cytometry – click here to read the news release.

Learn more about our experience in anatomic and molecular pathology and genomics-based assay development and testing that provide customized, end-to-end solutions for our customers.
Tumor Mutational Burden (TMB) Assay for Response to Immunotherapy

TMB assay utilizing whole exome sequencing (WES) methodology and proprietary variant analysis compendium

Anatomic Pathology brochure

Comprehensive in-house end-to-end anatomic pathology and adjunct molecular services

Validating Flow Cytometry Assays for Immuno-Oncology Trials in the Central Lab

Molecular Medicine Tri-Conference 2017

Q2 Solutions Central Laboratory Services

Optimized logistics, deeper science, better insights

Planning and implementing biomarker testing for immuno-oncology trials

Exploring the challenges with the diverse clinical biomarker requirements

Fulfilling the Potential of Flow Cytometry: Standardization & Automation 

Molecular Medicine Tri-Conference 2017 

Read More